Prostate-specific membrane antigen (PSMA) PET/CT has become the gold standard for staging and restaging prostate cancer, with superior diagnostic accuracy over conventional imaging and established prognostic value. However, there are limited data on whether PSMA PET/CT-improved staging accuracy is associated with impro...
Sima Esmaeilzadeh Asl, S. Hoberück, A. Sonnenfeld et al.· Journal of Nuclear Medicine· 0 citations
Simple Summary When cancer is diagnosed in a child, it is essential to determine whether it has spread to other parts of the body, because this influences treatment and the chances of recovery. Positron-emission tomography combined with computed tomography is a common diagnostic test that is used for this purpose. Howe...
André Lollert, Maximilian Wittmann, F. Souschek et al.· Cancers· 0 citations
BACKGROUND AND OBJECTIVE
Prostate-specific membrane-antigen positron emission tomography (PSMA-PET) detects distant metastases in more than half of patients with increasing prostate-specific antigen despite castrate levels of testosterone and high-risk nonmetastatic disease on conventional imaging. Here, we aim to eval...
C. Civan, M. Karpinski, C. Darr et al.· European Urology Focus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.